Abstract
Objectives The COVID-19 pandemic was associated with significant changes in preventive behaviors worldwide. We conducted a cohort follow-up survey to understand these behavioral changes in Taiwan during 2020 and 2021. Methods A population-based survey with three follow-up rounds was implemented among individuals aged 20 and older. The survey included questions about perceptions of COVID-19 risk and adherence to preventive behaviors promoted by the Taiwan CDC in its New Life Strategies. Results Between July and September 2020, a period with no local COVID-19 cases, adherence to indoor and outdoor social distancing was 51.5% and 63.5%, respectively, while 81.4% of people indicated they would wear facial masks if social distancing could not be practiced. In stratified analysis, females and the elderly exhibited significantly higher adherence to most of the preventive measures. We observed an increase in adherence to preventive behaviors from 2020 to the middle of 2021, with no signs of fatigue. Conclusions The survey provided critical empirical evidence on the adherence to preventive behaviors in the general population in Taiwan during the first two years of the pandemic. As non-pharmaceutical interventions (NPI) are essential measures during the early stage of any pandemic, we believe that regular monitoring of preventive behaviors could serve as a foundation for pandemic preparedness. More efforts are needed to identify the most feasible and cost-effective methods for surveillance of preventive behaviors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funding by Taiwan Centers of Disease Control, project LA109025.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Research Ethics Committee of National Taiwan University (202007HM008).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos